Table 2.
Detailed information and characteristics of included studies.
| Studies | Country | Age (y) | Female/Male | Sample Size (n) | Duration | Follow-Up (w) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| BT | con | BT | con | BT | con | BT | con | |||
| Fioravanti et al., 2018 [32] | Italy | 56.16 ± 8.74 | 55.9 ± 6.61 | 48/2 | 47/3 | 50 | 50 | 16.02 ± 12.58 m | 15.08 ± 10.87 m | 24 |
| Fernández et al., 2019 [33] | Spain | 52.4 ± 8.6 | 53.4 ± 11.3 | 23/2 | 25/0 | 25 | 25 | NA | NA | 12 |
| Dönmez et al., 2005 [26] | Turkey | 43.3 ± 7.5 | 43.1 ± 6.9 | NA | NA | 16 | 13 | 11.5 ± 8.5 y | 11.8 ± 7.5 y | 36 |
| Özkurt et al., 2012 [30] | Italy | 50.8 ± 6 | 46.87 ± 8.8 | 21/0 | 24/0 | 21 | 24 | 12.9 ± 7 y | 11.29 ± 6.2 y | 12 |
| Zijlstra et al., 2005 [34] | The Netherlands | 48 | 47 | 55/3 | 73/3 | 58 | 76 | 10 m | 10 m | 48 |
| Bağdatlı et al., 2015 [29] | Turkey | 45.17 ± 9.09 | 42.77 ± 9.59 | 35/0 | 35/0 | 35 | 35 | 8.83 ± 4.74 y | 8.37 ± 5.49 y | 12 |
| Evcik et al., 2002 [25] | Turkey | 42 ± 6.8 | 41.5 ± 7.1 | 16/6 | 15/5 | 22 | 20 | 15.5 ± 7.2 m | 14.1 ± 8.7 m | 24 |
| Ardıç et al., 2007 [27] | Turkey | 43.5 ± 10.2 | 48.8 ± 8.8 | NA | NA | 12 | 9 | 23.4 ± 21.5 m | 30.6 ± 28.6 m | 3 |
| Yurtkuran et al., 1996 [8] | Turkey | 37.5 | 33.4 | 19/1 | 18/2 | 20 | 20 | NA | NA | 6 |
| Fioravanti et al., 2007 [31] | Italy | 46.2 ± 10.5 | 48.6 ± 9.4 | 39/1 | 39/1 | 40 | 40 | 2.21 ± 1.35 y | 2.30 ± 1.42 y | 16 |
| Koçyiğit et al., 2016 [28] | Turkey | 42.45 ± 9.93 | 41.77 ± 10.5 | 31/0 | 30/0 | 31 | 30 | 73.65 ± 59.15 m | 69.40 ± 40.1 m | 24 |
BT, balneotherapy; con, control; NA, not available; y, years; m, months; w, weeks.